Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Dancing as an Alternative to the Traditional Exercising in Older Adults With Cardiac Diseases (1382)

8 septembre 2026 mis à jour par: University College, London

The Effectiveness of Azerbaijani National Dances on Cardiorespiratory Fitness and Quality of Life of Older Adults With Chronic Heart Failure Diagnosis

According to the Global Burden of Disease Study (2017) 64 million people worldwide are living with Heart Failure (HF). Risk factors of HF include age, history of coronary heart disease, atrial fibrillation, hypertension, diabetes mellitus, smoking and low physical activity.

There is clear evidence that regular physical activity can increase life expectancy and improve cognitive function, and delay functional disabilities associated with aging. Physical Activity and exercise training is considered as one of the components cardiovascular disease prevention and rehabilitation program. There is a growing scientific support that cardiac rehabilitation (CR) slows, stabilizes or regresses cardiovascular disease (CVD). In addition, it has been shown that CR programs significantly reduce re-hospitalisation and death from CVDs by up to 25%.

Despite of strong evidence of the positive effects of exercise training in Chronic HF patients, the adherence to the exercise component of CR is still not at the level recommended by the international physical activity guidelines. Patients participating in physical activity programs are faced with several obstacles, such as orthopaedic limitations to exercise, or being severely overweight. Another most common barriers for participating in CR are family and employment obligation, psychological well-being and age ("CR is only for adults"). Participation of older adults in physical exercises programs is highly influenced by their personal interest in activity type, engagement and perceived advantages. The author is also mentioned that engaging in different types of activities or adding new elements to the traditional exercises may increase and maintain individuals' interest and engagement in physical activity. This will improve their commitment t the regular exercise and leading to improved health outcomes.

World Health Organisation defines dance as a type of physical activity and recommends its implementation to develop physical skills, especially in the least active population groups. Scientists highlight the advantages of dancing over traditional strength and balance exercises that are often performed individually, whereas dance is predominantly a group activity.

According to the Ministry of Culture of the Republic Azerbaijan, Azerbaijani traditional dances represent the ancient culture of the country and are popular activity among both young and older people. Azerbaijani dancing has a major social role in bringing people together during celebration of National Holidays and family events.

However, use of traditional dancing in general, and Azerbaijani dances particularly, as an intervention in CR programs has not been well established. Screening of reports published since 2015, revealed only randomized control studies which identified the dance intervention as national/cultural dancing style. All those studies demonstrated positive impact of traditional dancing on the functional capacity and psychological condition of people with chronic diseases.

More research on the use of the cultural dancing as an alternative to traditional exercise programs as a part of CR could provide clearer evidence about the role and effectiveness of traditional dance in CR.

The aim of this research is to investigate the impact of Azerbaijani Cultural Dances on cardiorespiratory fitness and quality of life of patients with chronic HF.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

120

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Baku, Azerbaïdjan, AZ1102
        • Azerbaijan Sports Academy

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Key Inclusion Criteria:

  • Echocardiography detected ejection fraction - 40-49% to justify the heart failure
  • Age between 65-85.

Exclusion Criteria:

  • Age below 65
  • Ejection fraction less than 40% and higher than 49%
  • Structural changes of the myocardium (aneurysms, scars, valvular diseases).
  • Signs of pleural or pericardial effusions
  • Clinically manifested comorbidities (unstable angina)
  • Uncontrolled Cardiac Arrhythmias

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Dancing arm. The intervention will last for 12 weeks, with a twice weekly session lasting 60 min.

Dance sessions will be delivered by the professional dance instructor who trained to work with older adults. Exercise session - by physiotherapist who is trained and has a bachelor's degree in Sport and Exercise Science. Considering that sessions are going to be conducted with one MD and one Nurse on site, 5-7 participants per each session are permitted for the easy observation and help in case of necessity. Only one dance/exercise instructor will attend the session.

Certified MD and nurse will observe the whole session. They both BLS and AED application trained. There is an EAD on site. Lab staff is instructed about contact details of Ambulance and Emergency services. The nearest Ambulance station is in 3 minutes driving distance. Each dancing sessions will consist of three phases: 15 min warm-up, 30 min dance, 15 minutes cooldown period. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic /endurance exercises.

Dance sessions will be delivered by the professional dance instructor who trained to work with older adults. Exercise session - by physiotherapist who is trained and has a bachelor's degree in Sport and Exercise Science.

Considering that sessions are going to be conducted with one MD and one Nurse on site, 5-7 participants per each session are permitted for the easy observation and help in case of necessity. Only one dance/exercise instructor will attend the session.

Certified MD and nurse will observe the whole session. They both BLS and AED application trained. There is an EAD on site.

Each dancing and exercising sessions will consist of three phases: 15 min warm-up, 30 min dance/exercise session, 15 minutes cooldown period.

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in pat

Comparateur actif: Exercising Group

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic /endurance exercises with low intensity about 40% of VO2 peak. This will continue for about 2 weeks. After 2 weeks the intensity will be gradually increased to 50-65% if tolerated with aiming to reach 70-75% by the end of the 12th week. In addition to the aerobic/endurance training, resistance training exercises will also be added to the structure of the sessions (the intensity level will be kept the same as with aerobic).

Warm-up is going to start with very low intensity aerobic/endurance training. Cool-down is stretching exercises and respiratory exercises (10-15 minutes).

Before and after each session blood pressure, resting HR and oxygen saturation will be measured.

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic/endurance exercises with low intensity about 40% of VO2 peak. This will continue for about 2 weeks. After 2 weeks the intensity will be gradually increased to 50-65% if tolerated with aiming to reach 70-75% by the end of the 12th week. In addition to the aerobic/endurance training, resistance training exercises will also be added to the structure of the sessions (the intensity level will be kept the same as with aerobic).

Warm-up is going to start with very low intensity aerobic/endurance training. Cool-down is stretching exercises and respiratory exercises (10-15 minutes).

Before and after each session blood pressure, resting HR and oxygen saturation will be measured.

Aucune intervention: Control Group
Control group participants will be asked to maintain their normal lifestyle during the 12-week period, including physical activity and social interaction patterns. Participants in the control group will undergo the same pre- and post intervention procedures at T-0 and T- 12.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Cardiorespiratory fitness
Délai: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Maximal Oxygen Capacity (VO2 max) is consiedered a gold standard in measuring cardiorespiratory fitness. Cardiopulmonary exercise testing will be conducted to all participants to measure cardiorespiratory fitness.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Quality of Life assessment
Délai: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Quality of life (QoL) is one of the factors that is highly impacted in the older adult population and defined as individuals' perception of their position in life in relation to their goals, expectations, standards, and concerns. Research shows that chronic heart failure (CHF) patients experience depression and sleeping disorders, resulting in poor QoL. The QoL will be measured with The Minnesota Living with Heart Failure Questionnaire (MLHFQ). Minimum value for this scale is 0 and maximum value is 105. The lower the score the better the outcome.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Muscle Strength
Délai: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
All participnats will go through muscle strength measurements using hand-held dynamometers. Hand grip strength (HGS), measured with a hand-held dynamometer, is suggested as a new clinical vital sign and is recommended for use as a measurement to identify older adults at risk of poor health status. Low HGS is associated with higher rates of hospitalization, mortality, and low QoL. HGS is also identified as a physical, behavioural, and psychological factor and is proposed as a health status indicator.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Fall Risk Assessment
Délai: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Fall risk will be assessed on Biodex Balance machine.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 août 2026

Achèvement primaire (Estimé)

28 février 2027

Achèvement de l'étude (Estimé)

31 mars 2027

Dates d'inscription aux études

Première soumission

11 août 2026

Première soumission répondant aux critères de contrôle qualité

8 septembre 2026

Première publication (Réel)

11 septembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

11 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Participants personal data includes full name, date of birth, age and gender, contact details and health information. This personal information will be coded and anonymised after the intervention phase of the study.

The collected anonymised data will be deleted 7 years after the publication of the results in academic sources.

The data will be available to be used for additional and subsequent research purposes within the 7 years period.

Délai de partage IPD

The information will be available as soon as the data collection completed until 7 years after.

Critères d'accès au partage IPD

The Principal Investigator will have access to the collected research data. UCL Statistician will have access to the anonymised research data. PhD supervisors will be given access to the anonymised data if they request data to answer specific questions.

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE
  • CIF
  • RSE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner